Wed. Oct 5th, 2022
Coronavirus vaccine: Bharat Biotech to use ViroVax#39;s adjuvant for Covaxin Bharat Biotech is currently conducting Phase II human trials of Covaxin after receiving approval from the Drug Controller General of India.